Blocking oncogenic Ras signaling for cancer therapy.

By A. Adjei. Journal of the National Cancer Institute, 2001

864 citations recorded by the source corpus.

Subfields: Molecular Biology

View Paper: https://www.semanticscholar.org/paper/f32cb9d5e280fbbafa490b7f47a88074da6a8c18

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Anthony M. Manning
2. Michael R. Stratton
3. R. Davis
4. Helen R. Davies
5. Meenhard Herlyn
6. S. Albelda

Citations in the corpus

• BRAF and RAS mutations in human lung cancer and melanoma. (2002, background): “Identification of gene mutations in human cancers can lead to the development of effective targeted therapies (1).”
• Targeting JNK for therapeutic benefit: from junk to gold? (2003, background): “A substantial body of evidence indicates that JNK activation and c-Jun phosphorylation are required for transformation induced by RAS , an oncogene that is mutationally activated in almost 30% of human cancer”